Anthera Pharmaceuticals Inc. buy melinda
Start price
22.02.18
/
50%
€2.16
Target price
11.09.18
€4.51
Performance (%)
-95.08%
End price
11.09.18
€0.11
Summary
This prediction ended on 11.09.18 with a price of €0.11. The BUY prediction by melinda for Anthera Pharmaceuticals Inc. performed very badly with a performance of -95.08%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Anthera Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by melinda for this prediction
In the thread Anthera Pharmaceuticals Inc. diskutieren
Biotechnologie und medizinische SecteurRecherche
Gainer
- Anthera Pharmaceuticals Inc. ANTH wurde von 43,79% sprang auf $ 2.43 Mittwoch zu schließen. Roth Kapital die Coverage auf Anthera Pharmaceuticals mit einem Buy - Rating und einem Zielpreis von $ 10.00.
(Vom Mitglied beendet)
Stopped prediction by melinda for Anthera Pharmaceuticals Inc.
Anthera Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.08
16.11.17
16.11.17
€4.51
20.12.17
20.12.17
-34.92%
20.12.17
20.12.17
Anthera Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.21
11.08.17
11.08.17
€1.80
13.11.17
13.11.17
41.88%
13.11.17
13.11.17
Anthera Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.34
11.08.17
11.08.17
€2.00
13.11.17
13.11.17
41.88%
13.11.17
13.11.17
Anthera Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€240.77
08.10.10
08.10.10
€281.60
11.04.11
11.04.11
23.90%
11.04.11
11.04.11